← Evidence map

ArticleRare diseases (Austin, Tex.)2013

GSK3β is a new therapeutic target for myotonic dystrophy type 1.

Christina Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25003008